J Mark FitzGerald Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

8/2023	Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
8/2022	Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
1/2022	Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPD.
1/2021	Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled Trials.
1/2021	The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study.
10/2020	The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
1/2020	An Individualized Prediction Model for Long-term Lung Function Trajectory and Risk of COPD in the General Population.
1/2020	Population-based case-finding to identify subjects with undiagnosed asthma or COPD.
12/2019	The effects of marijuana smoking on lung function in older people.
8/2019	Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Mark FitzGerald Research Topics

Disease

115	Asthma (Bronchial Asthma) 11/2023 - 11/2003
33	Chronic Obstructive Pulmonary Disease (COPD) 08/2023 - 01/2005
13	Inflammation (Inflammations) 01/2023 - 05/2014
4	Symptom Flare Up 01/2022 - 01/2022
4	Infections 01/2013 - 09/2008
3	Respiratory Sounds (Crackle) 09/2015 - 11/2009
3	Dyspnea (Shortness of Breath) 01/2013 - 10/2005
3	Tuberculosis (Tuberculoses) 09/2011 - 09/2005
2	Allergic Rhinitis 11/2023 - 11/2020
2	Nasal Polyps (Nasal Polyp) 11/2023 - 01/2021
2	Fibrosis (Cirrhosis) 12/2020 - 02/2012
2	Airway Remodeling 12/2020 - 01/2018
2	Latent Tuberculosis 01/2020 - 01/2013
2	Eosinophilia 01/2018 - 10/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 09/2009
1	Rhinosinusitis 11/2023
1	Atopic Dermatitis (Atopic Eczema) 11/2023
1	Dermatitis 11/2023
1	Obesity 08/2023
1	Dyslipidemias (Dyslipidemia) 08/2023
1	Bronchiectasis 08/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Bronchitis 01/2023
1	Eczema 01/2021
1	Perennial Allergic Rhinitis 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Pneumonia (Pneumonitis) 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Pulmonary Edema 01/2018
1	Adenoma (Adenomas) 01/2017
1	Pancytopenia 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2016
1	Nasopharyngitis 10/2016

Drug/Important Bio-Agent (IBA)

57	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 11/2003
19	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 11/2003
16	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2016
15	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 01/2005
15	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 11/2003
11	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 03/2017
11	benralizumabIBA 01/2022 - 10/2016
8	AllergensIBA 01/2023 - 11/2012
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 05/2014
8	Terbutaline (Brethaire)FDA LinkGeneric 12/2021 - 01/2008
8	Monoclonal AntibodiesIBA 12/2020 - 10/2016
6	mepolizumabIBA 05/2023 - 09/2014
6	SteroidsIBA 01/2023 - 04/2005
6	dupilumabIBA 01/2023 - 01/2018
6	Immunoglobulin E (IgE)IBA 11/2022 - 10/2016
6	Tiotropium Bromide (Spiriva)FDA Link 11/2020 - 01/2005
5	Methacholine Chloride (Methacholine)FDA Link 01/2023 - 01/2018
5	Muscarinic AntagonistsIBA 01/2022 - 11/2020
5	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2021 - 04/2012
5	Formoterol Fumarate Drug Combination Budesonide FDA Link 12/2021 - 11/2003
5	GlucocorticoidsIBA 10/2021 - 09/2014
5	Interleukin-13IBA 12/2020 - 01/2017
4	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2017
4	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2022
4	Omalizumab (Xolair)FDA Link 01/2022 - 11/2015
3	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2019 - 10/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 10/2005
3	Salmeterol Xinafoate (Serevent)FDA Link 09/2014 - 01/2005
2	ORALIT (ORS)IBA 08/2023 - 03/2011
2	anti-IgE antibodiesIBA 01/2023 - 01/2021
2	reslizumabIBA 01/2022 - 12/2019
2	Interleukin-4 (Interleukin 4)IBA 11/2020 - 01/2017
2	InterleukinsIBA 11/2020 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 01/2013
2	Prednisone (Sone)FDA LinkGeneric 08/2019 - 02/2013
2	GoldIBA 01/2019 - 11/2016
2	C-Reactive ProteinIBA 01/2018 - 01/2017
2	CytokinesIBA 01/2017 - 05/2014
2	Fluticasone (Cutivate)FDA LinkGeneric 09/2014 - 04/2005
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 09/2014 - 01/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2009 - 06/2006
2	Oxygen (Dioxygen)IBA 07/2009 - 01/2007
1	Immunoglobulin FragmentsIBA 01/2023
1	insulin receptor-related receptor (IRR)IBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	NemiralisibIBA 01/2021
1	lebrikizumabIBA 12/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2019
1	antiarrhythmic peptide (AAP)IBA 10/2018
1	PlacebosIBA 01/2018
1	tralokinumabIBA 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	Natriuretic PeptidesIBA 10/2017
1	PeriostinIBA 09/2017
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2017

Therapy/Procedure

55	Therapeutics 05/2023 - 11/2003
11	Nebulizers and Vaporizers (Inhaler) 11/2019 - 11/2003
9	Biological Therapy 02/2024 - 12/2021
3	Drug Therapy (Chemotherapy) 04/2021 - 10/2014
2	Precision Medicine 05/2023 - 01/2019
2	Ambulatory Care (Outpatient Care) 02/2016 - 09/2011
2	Bronchial Thermoplasty 01/2016 - 09/2015
1	Inappropriate Prescribing 03/2017